Revenio Group Oyj (0KFH.L)
EUR 26.78
(1.9%)
EUR 26.78
(1.9%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.72 EUR | -12.2% |
| 2022 | 0.82 EUR | 26.15% |
| 2021 | 0.65 EUR | 30.0% |
| 2020 | 0.50 EUR | 38.89% |
| 2019 | 0.36 EUR | 5.88% |
| 2018 | 0.34 EUR | 17.24% |
| 2017 | 0.29 EUR | 26.09% |
| 2016 | 0.23 EUR | -17.86% |
| 2015 | 0.28 EUR | 1052.38% |
| 2014 | -0.03 EUR | -115.47% |
| 2013 | 0.19 EUR | 1620.0% |
| 2012 | -0.01 EUR | -107.35% |
| 2011 | 0.17 EUR | 872.73% |
| 2010 | -0.02 EUR | 37.85% |
| 2009 | -0.04 EUR | -129.5% |
| 2008 | 0.12 EUR | 0.0% |
| 2005 | 0.15 EUR | 318.66% |
| 2004 | -0.07 EUR | 68.82% |
| 2003 | -0.22 EUR | 66.67% |
| 2002 | -0.66 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.14 EUR | -48.15% |
| 2024 Q3 | 0.16 EUR | 6.67% |
| 2024 Q2 | 0.15 EUR | 7.14% |
| 2023 Q2 | 0.12 EUR | -25.0% |
| 2023 Q1 | 0.16 EUR | -23.81% |
| 2023 FY | - EUR | -12.2% |
| 2023 Q4 | 0.27 EUR | 58.82% |
| 2023 Q3 | 0.17 EUR | 41.67% |
| 2022 Q1 | 0.18 EUR | 0.0% |
| 2022 FY | - EUR | 26.15% |
| 2022 Q4 | 0.21 EUR | -8.7% |
| 2022 Q3 | 0.23 EUR | 15.0% |
| 2022 Q2 | 0.20 EUR | 11.11% |
| 2021 Q1 | 0.14 EUR | -36.36% |
| 2021 FY | - EUR | 30.0% |
| 2021 Q4 | 0.18 EUR | 0.0% |
| 2021 Q3 | 0.18 EUR | 38.46% |
| 2021 Q2 | 0.13 EUR | -7.14% |
| 2020 FY | - EUR | 38.89% |
| 2020 Q2 | 0.10 EUR | 29.33% |
| 2020 Q3 | 0.11 EUR | 13.4% |
| 2020 Q1 | 0.08 EUR | -50.0% |
| 2020 Q4 | 0.22 EUR | 100.0% |
| 2019 FY | - EUR | 5.88% |
| 2019 Q1 | 0.09 EUR | -14.0% |
| 2019 Q4 | 0.15 EUR | 25.0% |
| 2019 Q3 | 0.12 EUR | 566.67% |
| 2019 Q2 | 0.02 EUR | -79.07% |
| 2018 Q1 | 0.07 EUR | -15.96% |
| 2018 Q4 | 0.10 EUR | 17.65% |
| 2018 FY | - EUR | 17.24% |
| 2018 Q2 | 0.08 EUR | 23.19% |
| 2018 Q3 | 0.08 EUR | 0.0% |
| 2017 Q1 | 0.06 EUR | -26.11% |
| 2017 FY | - EUR | 26.09% |
| 2017 Q3 | 0.08 EUR | 15.96% |
| 2017 Q4 | 0.08 EUR | -3.41% |
| 2017 Q2 | 0.07 EUR | 22.17% |
| 2016 FY | - EUR | -17.86% |
| 2016 Q4 | 0.08 EUR | 35.33% |
| 2016 Q2 | 0.06 EUR | 50.0% |
| 2016 Q3 | 0.06 EUR | 0.0% |
| 2016 Q1 | 0.04 EUR | 23.84% |
| 2015 Q1 | 0.05 EUR | 148.45% |
| 2015 FY | - EUR | 1052.38% |
| 2015 Q4 | 0.03 EUR | -52.5% |
| 2015 Q3 | 0.07 EUR | -47.69% |
| 2015 Q2 | 0.13 EUR | 143.9% |
| 2014 Q2 | 0.06 EUR | -28.0% |
| 2014 Q1 | 0.08 EUR | 40.6% |
| 2014 FY | - EUR | -115.47% |
| 2014 Q4 | -0.11 EUR | -228.36% |
| 2014 Q3 | -0.03 EUR | -158.16% |
| 2013 Q4 | 0.06 EUR | 21.58% |
| 2013 Q3 | 0.05 EUR | 10.12% |
| 2013 Q1 | 0.06 EUR | 323.23% |
| 2013 Q2 | 0.04 EUR | -25.04% |
| 2013 FY | - EUR | 1620.0% |
| 2012 FY | - EUR | -107.35% |
| 2012 Q1 | 0.01 EUR | 221.95% |
| 2012 Q3 | 0.04 EUR | 212.39% |
| 2012 Q2 | -0.03 EUR | -447.0% |
| 2012 Q4 | -0.03 EUR | -165.13% |
| 2011 Q3 | 0.12 EUR | 207.69% |
| 2011 Q4 | -0.01 EUR | -106.83% |
| 2011 FY | - EUR | 872.73% |
| 2011 Q1 | 0.03 EUR | 185.71% |
| 2011 Q2 | 0.04 EUR | 30.0% |
| 2010 Q3 | 0.03 EUR | 498.85% |
| 2010 Q1 | -0.01 EUR | 99.93% |
| 2010 FY | - EUR | 37.85% |
| 2010 Q2 | -0.01 EUR | 13.0% |
| 2010 Q4 | -0.04 EUR | -200.86% |
| 2009 Q1 | -6.67 EUR | 0.0% |
| 2009 Q4 | -14.00 EUR | -415.32% |
| 2009 FY | - EUR | -129.5% |
| 2009 Q3 | 4.44 EUR | 133.31% |
| 2009 Q2 | -13.33 EUR | -99.85% |
| 2008 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 318.66% |
| 2004 FY | - EUR | 68.82% |
| 2003 FY | - EUR | 66.67% |
| 2002 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Cegedim SA | -0.54 EUR | 233.333% |
| Guerbet SA | 1.90 EUR | 62.105% |
| Nexus AG | 1.39 EUR | 48.201% |
| Bastide Le Confort Médical SA | -0.12 EUR | 700.0% |
| Drägerwerk AG & Co. KGaA | 5.89 EUR | 87.776% |
| Sartorius Aktiengesellschaft | 3.00 EUR | 76.0% |
| LNA Santé SA | 2.29 EUR | 68.559% |
| Siemens Healthineers AG | 1.74 EUR | 58.621% |
| Medios AG | 0.79 EUR | 8.861% |
| Equasens Société anonyme | 3.13 EUR | 76.997% |
| Stratec SE | 1.07 EUR | 32.71% |